Hap Trading, LLC Protalix Bio Therapeutics, Inc. Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 100,400 shares of PLX stock, worth $188,752. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,400Holding current value
$188,752% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
50Shares Held
3.58MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny956KShares$1.8 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$818,2000.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny374KShares$702,6630.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$626,3610.0% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$507,6000.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $93.5M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...